QualityStocks Stock Newsletters Archives - Page 988 of 1818

MondayJul 07, 2008 6:57 am

Unigene Labs Inc. (UGNE.OB) Breaks Ground on New Biotechnology Plant, Eye’s Chinese Peptide Market

Having a “white knight” hanging around to give your company a nice infusion of cash is always a nice incentive to taking a bit of a risk. New market entry is always a bit of a risk, even if you have an established product to enter that market with. Not being 100% sure of how that new market will react – socially and financially - to a new product is always the risk. But if the “white knight” is willing to support in more than just a monetary way, the chances of sizable profit can be increased considerably. Unigene Labs…

MondayJul 07, 2008 6:13 am

Positive Phase 2 Clinical Trial for Provectus Pharmaceuticals Inc. (PVCT.OB) Drug

Provectus Pharmaceuticals Inc. (PVCT.OB) is a Tennessee-based development stage pharmaceutical company that specializes in oncology and dermatology therapies. Complementing the company's lineup of proprietary drugs, Provectus has developed a number of intellectual properties and technologies in the areas of imaging, medical devices, and biotechnology. In the biotechnology area, the company has developed groundbreaking technology to augment vaccine production and detect viruses. Another area that Provectus is focusing on is the dermatology space. The company is currently conducting Phase 2 clinical trials of their proprietary drug PH-10, to be used as a topical treatment for psoriasis and atopic dermatitis. Provectus Pharma's…

MondayJul 07, 2008 5:46 am

Which Small Capital Stocks Will Graduate to the Big League: Part 3 of 10

Marketing metrics is a sword with two sharp edges. It highlights top stocks of the future. Investors from the finance world rarely appreciate the method. In fact, many may not be aware of it at all. Start with the consumer decision-making process. Fast moving consumer goods are bought frequently. Buying expensive cars and new homes take place just once in a blue moon. Children's choices are often overturned by parents. Soldiers in Iraq must eat whatever Washington buys. You must know how buying decisions are made, and how often. Word-of-mouth matters for expensive purchases. Therefore, satisfaction levels of present owners…

MondayJul 07, 2008 5:41 am

Does Outsourcing Threaten Your Stock Portfolio?

Employees are not the only ones seriously affected by outsourcing. Large banks have outsourced customer accounts to third parties. There has been at least one instance of call-center employees making fraudulent transactions. Examples of poor service abound. Investments in branding are wasted, apart from the crippling loss of customer goodwill. This kind of outsourcing may be to a foreign national who was previously employed by the bank. That is why employees move swiftly to brush outsourcing dirt under the carpet. Presidential candidates speak of national employment effects of sending jobs abroad, but the effects on stocks have been hidden from…

MondayJul 07, 2008 4:02 am

How to Grow a Business & Stock Investment Mind – The Productive Weekend Series Part 2

Those of us who have trudged the stock market rings of yesteryear sense changes already. We used to get thrills by guessing stock price trends in the U.S. from developments in Japan. Now, this has become common knowledge. Dealing in other countries and currencies is as easy as trading in ADRs on the NYSE or NASDAQ. No BRIC country mattered until the 1990s. A new U.S. administration in 2009 could bring revolutionary changes. The communists of China have shown an unexpected appetite for business. India is almost a new country in economic terms. New sectors have sprung up in California,…

MondayJul 07, 2008 3:58 am

Vanda Pharmaceuticals Inc. (VNDA) – A Stock Domain Experts Should Watch

It takes decades for the average person to understand clinical trials. People who are not from the pharmaceutical sciences find it especially hard to know whether a new drug will meet regulatory standards. This can lead to stock prices that do not reflect business prospects squarely. Conservatism pays in the Biotechnology & Drugs Sector. The best interests of stock investors are not served by management teams who gloss over the weaknesses of their research molecules. Investments are best entrusted to executives with objective views of product trials. Pharmaceutical trials are continuous. They continue even with marketed products. The industry relies…

MondayJul 07, 2008 3:55 am

Voyant International’s (VOYT.OB) Senior Management Converts Owed Back-Pay to Preferred Stock

Voyant International (VOYT.OB), a media holding company focused on bridging innovative technologies, media assets and strategic partnerships to deliver next-generation commercial and consumer solutions, recently announced that senior management is still committed to supporting the growth of the company. Back in December 2007, senior officers agreed to defer a portion of their pay to support the company’s growth and provide all the resources it needed to start operating as a revenue-bearing enterprise. In recent news, senior management has now decided to convert their owed back pay into preferred stock in lieu of a cashable paycheck. Management notes this action as…

MondayJul 07, 2008 3:53 am

CEP in Any Mode Please

Travel-related enterprises have been quick off-the-blocks. You may not distinguish Complex Event Processing (CEP) from older versions of Service Oriented Architecture (SOA); however, you are probably a beneficiary every time you buy a ticket or reserve accommodations. Complex Event Processing could leave your own business behind the competition. It is certainly a significant driver of future enterprise development. Customer service now beats tangible product features in many categories. Information Technology experts like to distinguish Complex Event Processing from Service Oriented Architecture. This is to akin to splitting hairs for the general manager or a stock investor. What use is any…

ThursdayJul 03, 2008 10:43 am

Navarre Corp. (NAVR) Subsidiary Shakes with Geneon Entertainment to Distribute Japanese Animation

FUNimation Entertainment is a wholly-owned subsidiary of Navarre Corp. (Nasdaq: NAVR), the leading Japanese animator in the United States. The company launches advancing brands, managing and distributing them for broadcasting, production, Internet, home video sales and distribution. The company today announced its partnership with Geneon Entertainment Inc., a leading producer of Japanese animation. Per the agreement, the companies will distribute select DVD titles in North America, and FUNimation will hold exclusive manufacturing, marketing, sales and distribution rights to Geneon’s established titles. Geneon’s current titles, such as “Ergo Proxy", “Hellsing Ultimate”, and “Black Lagoon", have experienced international success, supporting FUNimation’s desire…

ThursdayJul 03, 2008 10:41 am

Ambac Financial Group Inc. (ABK) Appoints New Member of Board with 30 Years Experience in Business/Finance

Ambac Financial Group Inc. (NYSE: ABK) is a holding company engaged in providing financial services in public and private sectors around the world. The company today announced Paul DeRosa, of hedge-fund management firm Mt. Lucas Management Corp., will join Ambac’s board of directors July 7, 2008. DeRosa is the seventh member of the board, and Ambac president and CEO Michael Callen said he believes DeRosa will prove beneficial to the company and its future endeavors. “The addition of Mr. DeRosa to our board further enhances its depth and expertise. His skills will be particularly valuable to Ambac at this time.…

Site Search

Company Search

Category: QualityStocks Stock Newsletters